nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—CYP2C9—brain cancer	0.472	1	CbGaD
Irbesartan—CYP2D6—Lomustine—brain cancer	0.0527	0.178	CbGbCtD
Irbesartan—CYP1A2—Carmustine—brain cancer	0.0522	0.176	CbGbCtD
Irbesartan—CYP2D6—Hydroxyurea—brain cancer	0.04	0.135	CbGbCtD
Irbesartan—CYP3A4—Temozolomide—brain cancer	0.0394	0.133	CbGbCtD
Irbesartan—PTGS1—Etoposide—brain cancer	0.0346	0.117	CbGbCtD
Irbesartan—CYP3A4—Lomustine—brain cancer	0.0335	0.113	CbGbCtD
Irbesartan—CYP2C8—Etoposide—brain cancer	0.02	0.0675	CbGbCtD
Irbesartan—CYP1A2—Etoposide—brain cancer	0.0155	0.0523	CbGbCtD
Irbesartan—CYP3A4—Etoposide—brain cancer	0.00811	0.0274	CbGbCtD
Irbesartan—JUN—ganglion—brain cancer	0.00283	0.0735	CbGeAlD
Irbesartan—JUN—endothelium—brain cancer	0.00244	0.0633	CbGeAlD
Irbesartan—JUN—blood vessel—brain cancer	0.00225	0.0584	CbGeAlD
Irbesartan—JUN—hindbrain—brain cancer	0.00215	0.0557	CbGeAlD
Irbesartan—AGTR1—endothelium—brain cancer	0.00184	0.0477	CbGeAlD
Irbesartan—AGTR1—blood vessel—brain cancer	0.0017	0.044	CbGeAlD
Irbesartan—Valsartan—CYP2C9—brain cancer	0.00144	0.445	CrCbGaD
Irbesartan—JUN—brainstem—brain cancer	0.00123	0.0319	CbGeAlD
Irbesartan—UGT1A3—endocrine gland—brain cancer	0.00122	0.0316	CbGeAlD
Irbesartan—JUN—telencephalon—brain cancer	0.00109	0.0283	CbGeAlD
Irbesartan—Candesartan—CYP2C9—brain cancer	0.00109	0.337	CrCbGaD
Irbesartan—EDNRA—pituitary gland—brain cancer	0.000975	0.0253	CbGeAlD
Irbesartan—EDNRA—medulla oblongata—brain cancer	0.00094	0.0244	CbGeAlD
Irbesartan—PTGS1—ganglion—brain cancer	0.000937	0.0243	CbGeAlD
Irbesartan—JUN—gonad—brain cancer	0.000911	0.0237	CbGeAlD
Irbesartan—JUN—pituitary gland—brain cancer	0.000889	0.0231	CbGeAlD
Irbesartan—EDNRA—midbrain—brain cancer	0.00086	0.0223	CbGeAlD
Irbesartan—JUN—medulla oblongata—brain cancer	0.000858	0.0223	CbGeAlD
Irbesartan—PTGS1—endothelium—brain cancer	0.000808	0.021	CbGeAlD
Irbesartan—JUN—midbrain—brain cancer	0.000784	0.0204	CbGeAlD
Irbesartan—JUN—spinal cord—brain cancer	0.000765	0.0199	CbGeAlD
Irbesartan—PTGS1—blood vessel—brain cancer	0.000745	0.0193	CbGeAlD
Irbesartan—Losartan—CYP2C9—brain cancer	0.000703	0.217	CrCbGaD
Irbesartan—JUN—endocrine gland—brain cancer	0.000689	0.0179	CbGeAlD
Irbesartan—JUN—head—brain cancer	0.00068	0.0176	CbGeAlD
Irbesartan—AGTR1—pituitary gland—brain cancer	0.00067	0.0174	CbGeAlD
Irbesartan—AGTR1—medulla oblongata—brain cancer	0.000646	0.0168	CbGeAlD
Irbesartan—JUN—central nervous system—brain cancer	0.000621	0.0161	CbGeAlD
Irbesartan—JUN—cerebellum—brain cancer	0.000607	0.0157	CbGeAlD
Irbesartan—CYP2D6—hindbrain—brain cancer	0.000584	0.0152	CbGeAlD
Irbesartan—EDNRA—brain—brain cancer	0.00054	0.014	CbGeAlD
Irbesartan—AGTR1—endocrine gland—brain cancer	0.000519	0.0135	CbGeAlD
Irbesartan—AGTR1—head—brain cancer	0.000512	0.0133	CbGeAlD
Irbesartan—JUN—brain—brain cancer	0.000493	0.0128	CbGeAlD
Irbesartan—AGTR1—central nervous system—brain cancer	0.000467	0.0121	CbGeAlD
Irbesartan—AGTR1—brain—brain cancer	0.000371	0.00963	CbGeAlD
Irbesartan—CYP2C8—pituitary gland—brain cancer	0.000363	0.00942	CbGeAlD
Irbesartan—PTGS1—telencephalon—brain cancer	0.000362	0.00938	CbGeAlD
Irbesartan—CYP2D6—brainstem—brain cancer	0.000335	0.00869	CbGeAlD
Irbesartan—CYP2D6—telencephalon—brain cancer	0.000297	0.00771	CbGeAlD
Irbesartan—PTGS1—pituitary gland—brain cancer	0.000294	0.00764	CbGeAlD
Irbesartan—Hyperglycaemia—Carmustine—brain cancer	0.000292	0.00301	CcSEcCtD
Irbesartan—Angiopathy—Hydroxyurea—brain cancer	0.00029	0.003	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Temozolomide—brain cancer	0.00029	0.003	CcSEcCtD
Irbesartan—Pneumonia—Carmustine—brain cancer	0.00029	0.00299	CcSEcCtD
Irbesartan—Shock—Procarbazine—brain cancer	0.000289	0.00298	CcSEcCtD
Irbesartan—Thrombocytopenia—Procarbazine—brain cancer	0.000288	0.00297	CcSEcCtD
Irbesartan—Chills—Hydroxyurea—brain cancer	0.000287	0.00297	CcSEcCtD
Irbesartan—Tachycardia—Procarbazine—brain cancer	0.000287	0.00296	CcSEcCtD
Irbesartan—Photosensitivity reaction—Temozolomide—brain cancer	0.000285	0.00294	CcSEcCtD
Irbesartan—Weight increased—Temozolomide—brain cancer	0.000284	0.00294	CcSEcCtD
Irbesartan—Hyperhidrosis—Procarbazine—brain cancer	0.000284	0.00293	CcSEcCtD
Irbesartan—Renal failure—Carmustine—brain cancer	0.000283	0.00293	CcSEcCtD
Irbesartan—Hyperglycaemia—Temozolomide—brain cancer	0.000282	0.00291	CcSEcCtD
Irbesartan—CYP2C8—endocrine gland—brain cancer	0.000281	0.0073	CbGeAlD
Irbesartan—Urinary tract infection—Carmustine—brain cancer	0.00028	0.00289	CcSEcCtD
Irbesartan—Pneumonia—Temozolomide—brain cancer	0.00028	0.00289	CcSEcCtD
Irbesartan—Anorexia—Procarbazine—brain cancer	0.00028	0.00289	CcSEcCtD
Irbesartan—Erythema—Hydroxyurea—brain cancer	0.000279	0.00288	CcSEcCtD
Irbesartan—Nausea—Lomustine—brain cancer	0.000275	0.00284	CcSEcCtD
Irbesartan—Hypotension—Procarbazine—brain cancer	0.000274	0.00283	CcSEcCtD
Irbesartan—Urinary tract infection—Temozolomide—brain cancer	0.000271	0.0028	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000268	0.00276	CcSEcCtD
Irbesartan—Paraesthesia—Procarbazine—brain cancer	0.000264	0.00272	CcSEcCtD
Irbesartan—Hepatobiliary disease—Temozolomide—brain cancer	0.000263	0.00272	CcSEcCtD
Irbesartan—CYP1A2—endocrine gland—brain cancer	0.000263	0.00683	CbGeAlD
Irbesartan—Somnolence—Procarbazine—brain cancer	0.000261	0.0027	CcSEcCtD
Irbesartan—Cramp muscle—Etoposide—brain cancer	0.00026	0.00269	CcSEcCtD
Irbesartan—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00026	0.00269	CcSEcCtD
Irbesartan—Ill-defined disorder—Hydroxyurea—brain cancer	0.000258	0.00267	CcSEcCtD
Irbesartan—Anaemia—Hydroxyurea—brain cancer	0.000257	0.00266	CcSEcCtD
Irbesartan—Hypoaesthesia—Carmustine—brain cancer	0.000257	0.00266	CcSEcCtD
Irbesartan—Decreased appetite—Procarbazine—brain cancer	0.000255	0.00264	CcSEcCtD
Irbesartan—Oedema peripheral—Carmustine—brain cancer	0.000255	0.00263	CcSEcCtD
Irbesartan—Connective tissue disorder—Carmustine—brain cancer	0.000254	0.00263	CcSEcCtD
Irbesartan—PTGS1—spinal cord—brain cancer	0.000253	0.00657	CbGeAlD
Irbesartan—Fatigue—Procarbazine—brain cancer	0.000253	0.00262	CcSEcCtD
Irbesartan—Malaise—Hydroxyurea—brain cancer	0.000251	0.00259	CcSEcCtD
Irbesartan—Pain—Procarbazine—brain cancer	0.000251	0.00259	CcSEcCtD
Irbesartan—Constipation—Procarbazine—brain cancer	0.000251	0.00259	CcSEcCtD
Irbesartan—Hepatitis—Temozolomide—brain cancer	0.00025	0.00258	CcSEcCtD
Irbesartan—Dysphagia—Etoposide—brain cancer	0.00025	0.00258	CcSEcCtD
Irbesartan—CYP2C9—endocrine gland—brain cancer	0.00025	0.00648	CbGeAlD
Irbesartan—Leukopenia—Hydroxyurea—brain cancer	0.000249	0.00258	CcSEcCtD
Irbesartan—Visual impairment—Carmustine—brain cancer	0.000249	0.00257	CcSEcCtD
Irbesartan—Hypoaesthesia—Temozolomide—brain cancer	0.000249	0.00257	CcSEcCtD
Irbesartan—Pharyngitis—Temozolomide—brain cancer	0.000248	0.00256	CcSEcCtD
Irbesartan—Urinary tract disorder—Temozolomide—brain cancer	0.000247	0.00255	CcSEcCtD
Irbesartan—Oedema peripheral—Temozolomide—brain cancer	0.000246	0.00254	CcSEcCtD
Irbesartan—Connective tissue disorder—Temozolomide—brain cancer	0.000246	0.00254	CcSEcCtD
Irbesartan—Urethral disorder—Temozolomide—brain cancer	0.000245	0.00253	CcSEcCtD
Irbesartan—Feeling abnormal—Procarbazine—brain cancer	0.000242	0.0025	CcSEcCtD
Irbesartan—Visual impairment—Temozolomide—brain cancer	0.000241	0.00249	CcSEcCtD
Irbesartan—Gastrointestinal pain—Procarbazine—brain cancer	0.00024	0.00248	CcSEcCtD
Irbesartan—Flushing—Carmustine—brain cancer	0.00024	0.00248	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000236	0.00243	CcSEcCtD
Irbesartan—Discomfort—Hydroxyurea—brain cancer	0.000234	0.00242	CcSEcCtD
Irbesartan—Neutropenia—Etoposide—brain cancer	0.000234	0.00241	CcSEcCtD
Irbesartan—Urticaria—Procarbazine—brain cancer	0.000233	0.00241	CcSEcCtD
Irbesartan—Tinnitus—Temozolomide—brain cancer	0.000233	0.00241	CcSEcCtD
Irbesartan—Body temperature increased—Procarbazine—brain cancer	0.000232	0.0024	CcSEcCtD
Irbesartan—Abdominal pain—Procarbazine—brain cancer	0.000232	0.0024	CcSEcCtD
Irbesartan—Flushing—Temozolomide—brain cancer	0.000232	0.0024	CcSEcCtD
Irbesartan—Cardiac disorder—Temozolomide—brain cancer	0.000232	0.0024	CcSEcCtD
Irbesartan—Arrhythmia—Carmustine—brain cancer	0.000231	0.00239	CcSEcCtD
Irbesartan—PTGS1—endocrine gland—brain cancer	0.000228	0.00592	CbGeAlD
Irbesartan—Oedema—Hydroxyurea—brain cancer	0.000227	0.00235	CcSEcCtD
Irbesartan—Angiopathy—Temozolomide—brain cancer	0.000227	0.00234	CcSEcCtD
Irbesartan—Infection—Hydroxyurea—brain cancer	0.000226	0.00233	CcSEcCtD
Irbesartan—Immune system disorder—Temozolomide—brain cancer	0.000226	0.00233	CcSEcCtD
Irbesartan—Mediastinal disorder—Temozolomide—brain cancer	0.000225	0.00233	CcSEcCtD
Irbesartan—Erythema—Carmustine—brain cancer	0.000225	0.00233	CcSEcCtD
Irbesartan—Malnutrition—Carmustine—brain cancer	0.000225	0.00233	CcSEcCtD
Irbesartan—PTGS1—head—brain cancer	0.000225	0.00584	CbGeAlD
Irbesartan—Chills—Temozolomide—brain cancer	0.000224	0.00232	CcSEcCtD
Irbesartan—Pneumonia—Etoposide—brain cancer	0.000224	0.00231	CcSEcCtD
Irbesartan—Nervous system disorder—Hydroxyurea—brain cancer	0.000223	0.0023	CcSEcCtD
Irbesartan—Thrombocytopenia—Hydroxyurea—brain cancer	0.000223	0.0023	CcSEcCtD
Irbesartan—Skin disorder—Hydroxyurea—brain cancer	0.000221	0.00228	CcSEcCtD
Irbesartan—Acute coronary syndrome—Etoposide—brain cancer	0.00022	0.00227	CcSEcCtD
Irbesartan—Renal failure—Etoposide—brain cancer	0.000219	0.00226	CcSEcCtD
Irbesartan—Myocardial infarction—Etoposide—brain cancer	0.000218	0.00226	CcSEcCtD
Irbesartan—Erythema—Temozolomide—brain cancer	0.000218	0.00225	CcSEcCtD
Irbesartan—Malnutrition—Temozolomide—brain cancer	0.000218	0.00225	CcSEcCtD
Irbesartan—Jaundice—Etoposide—brain cancer	0.000217	0.00224	CcSEcCtD
Irbesartan—Anorexia—Hydroxyurea—brain cancer	0.000217	0.00224	CcSEcCtD
Irbesartan—Hypersensitivity—Procarbazine—brain cancer	0.000216	0.00224	CcSEcCtD
Irbesartan—Dysgeusia—Temozolomide—brain cancer	0.000213	0.0022	CcSEcCtD
Irbesartan—Vision blurred—Carmustine—brain cancer	0.000212	0.00219	CcSEcCtD
Irbesartan—Tremor—Carmustine—brain cancer	0.000211	0.00218	CcSEcCtD
Irbesartan—Asthenia—Procarbazine—brain cancer	0.000211	0.00218	CcSEcCtD
Irbesartan—Hepatobiliary disease—Etoposide—brain cancer	0.000211	0.00218	CcSEcCtD
Irbesartan—Anaemia—Carmustine—brain cancer	0.000208	0.00215	CcSEcCtD
Irbesartan—Agranulocytosis—Etoposide—brain cancer	0.000208	0.00215	CcSEcCtD
Irbesartan—Pruritus—Procarbazine—brain cancer	0.000208	0.00215	CcSEcCtD
Irbesartan—Agitation—Carmustine—brain cancer	0.000207	0.00214	CcSEcCtD
Irbesartan—PTGS1—central nervous system—brain cancer	0.000206	0.00533	CbGeAlD
Irbesartan—Vision blurred—Temozolomide—brain cancer	0.000205	0.00212	CcSEcCtD
Irbesartan—Tremor—Temozolomide—brain cancer	0.000204	0.00211	CcSEcCtD
Irbesartan—Dyspnoea—Hydroxyurea—brain cancer	0.000203	0.00209	CcSEcCtD
Irbesartan—Somnolence—Hydroxyurea—brain cancer	0.000202	0.00209	CcSEcCtD
Irbesartan—Ill-defined disorder—Temozolomide—brain cancer	0.000202	0.00209	CcSEcCtD
Irbesartan—Leukopenia—Carmustine—brain cancer	0.000202	0.00208	CcSEcCtD
Irbesartan—CYP2C8—brain—brain cancer	0.000201	0.00522	CbGeAlD
Irbesartan—Anaemia—Temozolomide—brain cancer	0.000201	0.00208	CcSEcCtD
Irbesartan—Diarrhoea—Procarbazine—brain cancer	0.000201	0.00208	CcSEcCtD
Irbesartan—Dyspepsia—Hydroxyurea—brain cancer	0.0002	0.00207	CcSEcCtD
Irbesartan—Agitation—Temozolomide—brain cancer	0.0002	0.00207	CcSEcCtD
Irbesartan—Hypoaesthesia—Etoposide—brain cancer	0.000199	0.00206	CcSEcCtD
Irbesartan—Angioedema—Temozolomide—brain cancer	0.000199	0.00205	CcSEcCtD
Irbesartan—Decreased appetite—Hydroxyurea—brain cancer	0.000198	0.00204	CcSEcCtD
Irbesartan—Urinary tract disorder—Etoposide—brain cancer	0.000198	0.00204	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000196	0.00203	CcSEcCtD
Irbesartan—Malaise—Temozolomide—brain cancer	0.000196	0.00203	CcSEcCtD
Irbesartan—Urethral disorder—Etoposide—brain cancer	0.000196	0.00203	CcSEcCtD
Irbesartan—Fatigue—Hydroxyurea—brain cancer	0.000196	0.00202	CcSEcCtD
Irbesartan—Vertigo—Temozolomide—brain cancer	0.000196	0.00202	CcSEcCtD
Irbesartan—Leukopenia—Temozolomide—brain cancer	0.000195	0.00201	CcSEcCtD
Irbesartan—Hypertension—Carmustine—brain cancer	0.000194	0.00201	CcSEcCtD
Irbesartan—Pain—Hydroxyurea—brain cancer	0.000194	0.00201	CcSEcCtD
Irbesartan—Constipation—Hydroxyurea—brain cancer	0.000194	0.00201	CcSEcCtD
Irbesartan—Dizziness—Procarbazine—brain cancer	0.000194	0.00201	CcSEcCtD
Irbesartan—Chest pain—Carmustine—brain cancer	0.000192	0.00198	CcSEcCtD
Irbesartan—Myalgia—Carmustine—brain cancer	0.000192	0.00198	CcSEcCtD
Irbesartan—Anxiety—Carmustine—brain cancer	0.000191	0.00197	CcSEcCtD
Irbesartan—CYP3A4—endocrine gland—brain cancer	0.00019	0.00494	CbGeAlD
Irbesartan—Cough—Temozolomide—brain cancer	0.00019	0.00196	CcSEcCtD
Irbesartan—Hypertension—Temozolomide—brain cancer	0.000188	0.00194	CcSEcCtD
Irbesartan—CYP2D6—endocrine gland—brain cancer	0.000187	0.00486	CbGeAlD
Irbesartan—Feeling abnormal—Hydroxyurea—brain cancer	0.000187	0.00193	CcSEcCtD
Irbesartan—Vomiting—Procarbazine—brain cancer	0.000187	0.00193	CcSEcCtD
Irbesartan—Flushing—Etoposide—brain cancer	0.000186	0.00192	CcSEcCtD
Irbesartan—Cardiac disorder—Etoposide—brain cancer	0.000186	0.00192	CcSEcCtD
Irbesartan—Arthralgia—Temozolomide—brain cancer	0.000185	0.00191	CcSEcCtD
Irbesartan—Myalgia—Temozolomide—brain cancer	0.000185	0.00191	CcSEcCtD
Irbesartan—Rash—Procarbazine—brain cancer	0.000185	0.00191	CcSEcCtD
Irbesartan—CYP2D6—head—brain cancer	0.000185	0.0048	CbGeAlD
Irbesartan—Dermatitis—Procarbazine—brain cancer	0.000185	0.00191	CcSEcCtD
Irbesartan—Anxiety—Temozolomide—brain cancer	0.000185	0.00191	CcSEcCtD
Irbesartan—Headache—Procarbazine—brain cancer	0.000184	0.0019	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000184	0.0019	CcSEcCtD
Irbesartan—Oedema—Carmustine—brain cancer	0.000184	0.0019	CcSEcCtD
Irbesartan—Discomfort—Temozolomide—brain cancer	0.000183	0.00189	CcSEcCtD
Irbesartan—Infection—Carmustine—brain cancer	0.000183	0.00189	CcSEcCtD
Irbesartan—Angiopathy—Etoposide—brain cancer	0.000181	0.00187	CcSEcCtD
Irbesartan—Dry mouth—Temozolomide—brain cancer	0.000181	0.00187	CcSEcCtD
Irbesartan—Immune system disorder—Etoposide—brain cancer	0.000181	0.00187	CcSEcCtD
Irbesartan—Mediastinal disorder—Etoposide—brain cancer	0.00018	0.00186	CcSEcCtD
Irbesartan—Thrombocytopenia—Carmustine—brain cancer	0.00018	0.00186	CcSEcCtD
Irbesartan—Body temperature increased—Hydroxyurea—brain cancer	0.00018	0.00186	CcSEcCtD
Irbesartan—Chills—Etoposide—brain cancer	0.000179	0.00185	CcSEcCtD
Irbesartan—Tachycardia—Carmustine—brain cancer	0.000179	0.00185	CcSEcCtD
Irbesartan—Oedema—Temozolomide—brain cancer	0.000178	0.00183	CcSEcCtD
Irbesartan—Anaphylactic shock—Temozolomide—brain cancer	0.000178	0.00183	CcSEcCtD
Irbesartan—Infection—Temozolomide—brain cancer	0.000176	0.00182	CcSEcCtD
Irbesartan—Anorexia—Carmustine—brain cancer	0.000175	0.00181	CcSEcCtD
Irbesartan—Nausea—Procarbazine—brain cancer	0.000174	0.0018	CcSEcCtD
Irbesartan—Nervous system disorder—Temozolomide—brain cancer	0.000174	0.0018	CcSEcCtD
Irbesartan—Thrombocytopenia—Temozolomide—brain cancer	0.000174	0.0018	CcSEcCtD
Irbesartan—Skin disorder—Temozolomide—brain cancer	0.000173	0.00178	CcSEcCtD
Irbesartan—Hypotension—Carmustine—brain cancer	0.000172	0.00177	CcSEcCtD
Irbesartan—Hyperhidrosis—Temozolomide—brain cancer	0.000172	0.00177	CcSEcCtD
Irbesartan—CYP3A4—central nervous system—brain cancer	0.000172	0.00445	CbGeAlD
Irbesartan—Dysgeusia—Etoposide—brain cancer	0.000171	0.00176	CcSEcCtD
Irbesartan—Anorexia—Temozolomide—brain cancer	0.000169	0.00175	CcSEcCtD
Irbesartan—CYP2D6—central nervous system—brain cancer	0.000169	0.00438	CbGeAlD
Irbesartan—Hypersensitivity—Hydroxyurea—brain cancer	0.000167	0.00173	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Carmustine—brain cancer	0.000167	0.00173	CcSEcCtD
Irbesartan—Muscle spasms—Etoposide—brain cancer	0.000167	0.00173	CcSEcCtD
Irbesartan—CYP2D6—cerebellum—brain cancer	0.000165	0.00428	CbGeAlD
Irbesartan—Paraesthesia—Carmustine—brain cancer	0.000165	0.0017	CcSEcCtD
Irbesartan—Dyspnoea—Carmustine—brain cancer	0.000164	0.00169	CcSEcCtD
Irbesartan—Somnolence—Carmustine—brain cancer	0.000163	0.00169	CcSEcCtD
Irbesartan—PTGS1—brain—brain cancer	0.000163	0.00423	CbGeAlD
Irbesartan—Asthenia—Hydroxyurea—brain cancer	0.000163	0.00168	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000162	0.00167	CcSEcCtD
Irbesartan—Ill-defined disorder—Etoposide—brain cancer	0.000162	0.00167	CcSEcCtD
Irbesartan—Anaemia—Etoposide—brain cancer	0.000161	0.00166	CcSEcCtD
Irbesartan—Decreased appetite—Carmustine—brain cancer	0.00016	0.00165	CcSEcCtD
Irbesartan—Paraesthesia—Temozolomide—brain cancer	0.000159	0.00165	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Carmustine—brain cancer	0.000159	0.00164	CcSEcCtD
Irbesartan—Dyspnoea—Temozolomide—brain cancer	0.000158	0.00164	CcSEcCtD
Irbesartan—Somnolence—Temozolomide—brain cancer	0.000158	0.00163	CcSEcCtD
Irbesartan—Pain—Carmustine—brain cancer	0.000157	0.00162	CcSEcCtD
Irbesartan—Constipation—Carmustine—brain cancer	0.000157	0.00162	CcSEcCtD
Irbesartan—Malaise—Etoposide—brain cancer	0.000157	0.00162	CcSEcCtD
Irbesartan—Vertigo—Etoposide—brain cancer	0.000156	0.00162	CcSEcCtD
Irbesartan—Dyspepsia—Temozolomide—brain cancer	0.000156	0.00161	CcSEcCtD
Irbesartan—Leukopenia—Etoposide—brain cancer	0.000156	0.00161	CcSEcCtD
Irbesartan—Diarrhoea—Hydroxyurea—brain cancer	0.000156	0.00161	CcSEcCtD
Irbesartan—Decreased appetite—Temozolomide—brain cancer	0.000154	0.00159	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Temozolomide—brain cancer	0.000153	0.00158	CcSEcCtD
Irbesartan—Fatigue—Temozolomide—brain cancer	0.000153	0.00158	CcSEcCtD
Irbesartan—Loss of consciousness—Etoposide—brain cancer	0.000153	0.00158	CcSEcCtD
Irbesartan—Cough—Etoposide—brain cancer	0.000152	0.00157	CcSEcCtD
Irbesartan—Pain—Temozolomide—brain cancer	0.000152	0.00157	CcSEcCtD
Irbesartan—Constipation—Temozolomide—brain cancer	0.000152	0.00157	CcSEcCtD
Irbesartan—Feeling abnormal—Carmustine—brain cancer	0.000151	0.00156	CcSEcCtD
Irbesartan—Hypertension—Etoposide—brain cancer	0.00015	0.00155	CcSEcCtD
Irbesartan—Dizziness—Hydroxyurea—brain cancer	0.00015	0.00155	CcSEcCtD
Irbesartan—Gastrointestinal pain—Carmustine—brain cancer	0.00015	0.00155	CcSEcCtD
Irbesartan—Chest pain—Etoposide—brain cancer	0.000148	0.00153	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000147	0.00152	CcSEcCtD
Irbesartan—Discomfort—Etoposide—brain cancer	0.000146	0.00151	CcSEcCtD
Irbesartan—Feeling abnormal—Temozolomide—brain cancer	0.000146	0.00151	CcSEcCtD
Irbesartan—Body temperature increased—Carmustine—brain cancer	0.000145	0.0015	CcSEcCtD
Irbesartan—Abdominal pain—Carmustine—brain cancer	0.000145	0.0015	CcSEcCtD
Irbesartan—Gastrointestinal pain—Temozolomide—brain cancer	0.000145	0.0015	CcSEcCtD
Irbesartan—Vomiting—Hydroxyurea—brain cancer	0.000145	0.00149	CcSEcCtD
Irbesartan—Rash—Hydroxyurea—brain cancer	0.000143	0.00148	CcSEcCtD
Irbesartan—Dermatitis—Hydroxyurea—brain cancer	0.000143	0.00148	CcSEcCtD
Irbesartan—Headache—Hydroxyurea—brain cancer	0.000142	0.00147	CcSEcCtD
Irbesartan—Anaphylactic shock—Etoposide—brain cancer	0.000142	0.00147	CcSEcCtD
Irbesartan—Infection—Etoposide—brain cancer	0.000141	0.00146	CcSEcCtD
Irbesartan—Urticaria—Temozolomide—brain cancer	0.000141	0.00146	CcSEcCtD
Irbesartan—Body temperature increased—Temozolomide—brain cancer	0.00014	0.00145	CcSEcCtD
Irbesartan—Abdominal pain—Temozolomide—brain cancer	0.00014	0.00145	CcSEcCtD
Irbesartan—Thrombocytopenia—Etoposide—brain cancer	0.000139	0.00144	CcSEcCtD
Irbesartan—Tachycardia—Etoposide—brain cancer	0.000139	0.00143	CcSEcCtD
Irbesartan—Skin disorder—Etoposide—brain cancer	0.000138	0.00143	CcSEcCtD
Irbesartan—Hyperhidrosis—Etoposide—brain cancer	0.000137	0.00142	CcSEcCtD
Irbesartan—Anorexia—Etoposide—brain cancer	0.000135	0.0014	CcSEcCtD
Irbesartan—Hypersensitivity—Carmustine—brain cancer	0.000135	0.0014	CcSEcCtD
Irbesartan—Nausea—Hydroxyurea—brain cancer	0.000135	0.00139	CcSEcCtD
Irbesartan—CYP2D6—brain—brain cancer	0.000134	0.00348	CbGeAlD
Irbesartan—Hypotension—Etoposide—brain cancer	0.000133	0.00137	CcSEcCtD
Irbesartan—Asthenia—Carmustine—brain cancer	0.000132	0.00136	CcSEcCtD
Irbesartan—Hypersensitivity—Temozolomide—brain cancer	0.000131	0.00135	CcSEcCtD
Irbesartan—Paraesthesia—Etoposide—brain cancer	0.000128	0.00132	CcSEcCtD
Irbesartan—Asthenia—Temozolomide—brain cancer	0.000127	0.00132	CcSEcCtD
Irbesartan—Dyspnoea—Etoposide—brain cancer	0.000127	0.00131	CcSEcCtD
Irbesartan—Somnolence—Etoposide—brain cancer	0.000126	0.0013	CcSEcCtD
Irbesartan—Diarrhoea—Carmustine—brain cancer	0.000126	0.0013	CcSEcCtD
Irbesartan—Pruritus—Temozolomide—brain cancer	0.000126	0.0013	CcSEcCtD
Irbesartan—Decreased appetite—Etoposide—brain cancer	0.000124	0.00128	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Etoposide—brain cancer	0.000123	0.00127	CcSEcCtD
Irbesartan—Fatigue—Etoposide—brain cancer	0.000123	0.00127	CcSEcCtD
Irbesartan—Dizziness—Carmustine—brain cancer	0.000122	0.00126	CcSEcCtD
Irbesartan—Constipation—Etoposide—brain cancer	0.000122	0.00126	CcSEcCtD
Irbesartan—Pain—Etoposide—brain cancer	0.000122	0.00126	CcSEcCtD
Irbesartan—Diarrhoea—Temozolomide—brain cancer	0.000122	0.00125	CcSEcCtD
Irbesartan—Dizziness—Temozolomide—brain cancer	0.000117	0.00121	CcSEcCtD
Irbesartan—Feeling abnormal—Etoposide—brain cancer	0.000117	0.00121	CcSEcCtD
Irbesartan—Vomiting—Carmustine—brain cancer	0.000117	0.00121	CcSEcCtD
Irbesartan—Gastrointestinal pain—Etoposide—brain cancer	0.000116	0.0012	CcSEcCtD
Irbesartan—Rash—Carmustine—brain cancer	0.000116	0.0012	CcSEcCtD
Irbesartan—Dermatitis—Carmustine—brain cancer	0.000116	0.0012	CcSEcCtD
Irbesartan—Headache—Carmustine—brain cancer	0.000115	0.00119	CcSEcCtD
Irbesartan—Vomiting—Temozolomide—brain cancer	0.000113	0.00117	CcSEcCtD
Irbesartan—Urticaria—Etoposide—brain cancer	0.000113	0.00117	CcSEcCtD
Irbesartan—Body temperature increased—Etoposide—brain cancer	0.000112	0.00116	CcSEcCtD
Irbesartan—Abdominal pain—Etoposide—brain cancer	0.000112	0.00116	CcSEcCtD
Irbesartan—Rash—Temozolomide—brain cancer	0.000112	0.00116	CcSEcCtD
Irbesartan—Dermatitis—Temozolomide—brain cancer	0.000112	0.00116	CcSEcCtD
Irbesartan—Headache—Temozolomide—brain cancer	0.000111	0.00115	CcSEcCtD
Irbesartan—Nausea—Carmustine—brain cancer	0.000109	0.00113	CcSEcCtD
Irbesartan—Nausea—Temozolomide—brain cancer	0.000105	0.00109	CcSEcCtD
Irbesartan—Hypersensitivity—Etoposide—brain cancer	0.000105	0.00108	CcSEcCtD
Irbesartan—Asthenia—Etoposide—brain cancer	0.000102	0.00105	CcSEcCtD
Irbesartan—Pruritus—Etoposide—brain cancer	0.000101	0.00104	CcSEcCtD
Irbesartan—Diarrhoea—Etoposide—brain cancer	9.72e-05	0.001	CcSEcCtD
Irbesartan—Dizziness—Etoposide—brain cancer	9.4e-05	0.000971	CcSEcCtD
Irbesartan—Vomiting—Etoposide—brain cancer	9.04e-05	0.000933	CcSEcCtD
Irbesartan—Rash—Etoposide—brain cancer	8.96e-05	0.000925	CcSEcCtD
Irbesartan—Dermatitis—Etoposide—brain cancer	8.95e-05	0.000925	CcSEcCtD
Irbesartan—Headache—Etoposide—brain cancer	8.9e-05	0.000919	CcSEcCtD
Irbesartan—Nausea—Etoposide—brain cancer	8.44e-05	0.000872	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—SHH—brain cancer	7.01e-05	0.000749	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—STAT3—brain cancer	6.84e-05	0.000732	CbGpPWpGaD
Irbesartan—JUN—ErbB1 downstream signaling—STAT3—brain cancer	6.84e-05	0.000732	CbGpPWpGaD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—MYC—brain cancer	6.78e-05	0.000724	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—TRPC6—brain cancer	6.76e-05	0.000723	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—SMO—brain cancer	6.65e-05	0.00071	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—PTCH1—brain cancer	6.65e-05	0.00071	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—CCND1—brain cancer	6.6e-05	0.000706	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—MYC—brain cancer	6.51e-05	0.000696	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—TP53—brain cancer	6.37e-05	0.00068	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—ERBB2—brain cancer	6.34e-05	0.000678	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PTCH2—brain cancer	6.31e-05	0.000674	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ABR—brain cancer	6.31e-05	0.000674	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—TP53—brain cancer	6.24e-05	0.000667	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CYP2C9—brain cancer	6.23e-05	0.000665	CbGpPWpGaD
Irbesartan—JUN—ErbB1 downstream signaling—EGFR—brain cancer	6.22e-05	0.000665	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—DTX2—brain cancer	6.22e-05	0.000665	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—MYC—brain cancer	6.17e-05	0.00066	CbGpPWpGaD
Irbesartan—JUN—Signaling by NOTCH—MYC—brain cancer	6.17e-05	0.00066	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HES5—brain cancer	6.11e-05	0.000653	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—CTNNB1—brain cancer	6.1e-05	0.000652	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—GLI2—brain cancer	6.09e-05	0.000651	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	5.98e-05	0.000639	CbGpPWpGaD
Irbesartan—JUN—PDGFR-beta signaling pathway—STAT3—brain cancer	5.95e-05	0.000636	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—RELA—brain cancer	5.95e-05	0.000636	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—CDKN2A—brain cancer	5.94e-05	0.000635	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—STRADA—brain cancer	5.93e-05	0.000634	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—CCND1—brain cancer	5.93e-05	0.000634	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—ERBB2—brain cancer	5.91e-05	0.000632	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDK4—brain cancer	5.87e-05	0.000628	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	5.87e-05	0.000628	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—TP53—brain cancer	5.86e-05	0.000626	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—TRPC6—brain cancer	5.84e-05	0.000624	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.76e-05	0.000615	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—GLI1—brain cancer	5.73e-05	0.000612	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—CTNNB1—brain cancer	5.72e-05	0.000611	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—RELA—brain cancer	5.72e-05	0.000611	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—ERBB2—brain cancer	5.58e-05	0.000597	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—VAV1—brain cancer	5.58e-05	0.000596	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.56e-05	0.000594	CbGpPWpGaD
Irbesartan—JUN—PDGFR-beta signaling pathway—MYC—brain cancer	5.53e-05	0.000591	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—SHH—brain cancer	5.5e-05	0.000588	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.48e-05	0.000586	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SUFU—brain cancer	5.43e-05	0.00058	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—TP53—brain cancer	5.35e-05	0.000571	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—STAT3—brain cancer	5.32e-05	0.000568	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—TRPC6—brain cancer	5.3e-05	0.000567	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—MYC—brain cancer	5.3e-05	0.000566	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—BSG—brain cancer	5.29e-05	0.000566	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—GFAP—brain cancer	5.24e-05	0.00056	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—TP53—brain cancer	5.22e-05	0.000558	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—PTCH1—brain cancer	5.21e-05	0.000557	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—SMO—brain cancer	5.21e-05	0.000557	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—VEGFA—brain cancer	5.17e-05	0.000553	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.09e-05	0.000544	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—TP53—brain cancer	5.07e-05	0.000542	CbGpPWpGaD
Irbesartan—JUN—Signaling by NOTCH—TP53—brain cancer	5.07e-05	0.000542	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—VAV1—brain cancer	5.06e-05	0.000541	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—VEGFA—brain cancer	5.04e-05	0.000538	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HEY1—brain cancer	4.97e-05	0.000531	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ABR—brain cancer	4.95e-05	0.000529	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—EGFR—brain cancer	4.94e-05	0.000528	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.94e-05	0.000528	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—CCND1—brain cancer	4.93e-05	0.000527	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.91e-05	0.000525	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—CTNNB1—brain cancer	4.89e-05	0.000522	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—DLL1—brain cancer	4.87e-05	0.000521	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.87e-05	0.00052	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—STAT3—brain cancer	4.84e-05	0.000517	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—GLI2—brain cancer	4.78e-05	0.000511	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—MYC—brain cancer	4.76e-05	0.000508	CbGpPWpGaD
Irbesartan—JUN—Oxidative Stress Induced Senescence—TP53—brain cancer	4.73e-05	0.000505	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PTCH2—brain cancer	4.71e-05	0.000504	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	4.69e-05	0.000502	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—VAV1—brain cancer	4.66e-05	0.000498	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—EGFR—brain cancer	4.65e-05	0.000497	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HES5—brain cancer	4.56e-05	0.000488	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—IDH1—brain cancer	4.55e-05	0.000487	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—GLI1—brain cancer	4.49e-05	0.00048	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDKN2A—brain cancer	4.49e-05	0.00048	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—STRADA—brain cancer	4.43e-05	0.000474	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—EGFR—brain cancer	4.4e-05	0.00047	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—VAV1—brain cancer	4.38e-05	0.000468	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—MYC—brain cancer	4.37e-05	0.000467	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TP53—brain cancer	4.35e-05	0.000465	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—STAT3—brain cancer	4.33e-05	0.000463	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—RELA—brain cancer	4.32e-05	0.000462	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—VEGFA—brain cancer	4.3e-05	0.00046	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.28e-05	0.000458	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—EGFR—brain cancer	4.27e-05	0.000457	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SUFU—brain cancer	4.26e-05	0.000455	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.2e-05	0.000448	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—TP53—brain cancer	4.15e-05	0.000444	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SHH—brain cancer	4.14e-05	0.000443	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—GFAP—brain cancer	4.11e-05	0.000439	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	4.1e-05	0.000438	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TRPC6—brain cancer	3.99e-05	0.000427	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—VAV1—brain cancer	3.97e-05	0.000425	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.94e-05	0.000421	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SMO—brain cancer	3.93e-05	0.00042	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PTCH1—brain cancer	3.93e-05	0.00042	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—TP53—brain cancer	3.91e-05	0.000417	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HEY1—brain cancer	3.9e-05	0.000417	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—EGFR—brain cancer	3.87e-05	0.000414	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.86e-05	0.000413	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.85e-05	0.000412	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—DLL1—brain cancer	3.82e-05	0.000408	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—PDGFRA—brain cancer	3.81e-05	0.000408	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.78e-05	0.000404	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.78e-05	0.000404	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.72e-05	0.000397	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ABR—brain cancer	3.7e-05	0.000395	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ENO2—brain cancer	3.6e-05	0.000385	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TP53—brain cancer	3.59e-05	0.000383	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—GLI2—brain cancer	3.57e-05	0.000382	CbGpPWpGaD
Irbesartan—JUN—Immune System—SKP2—brain cancer	3.56e-05	0.00038	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—PIK3CG—brain cancer	3.54e-05	0.000379	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.54e-05	0.000378	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP2C9—brain cancer	3.51e-05	0.000375	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—GLI1—brain cancer	3.36e-05	0.000359	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IRS2—brain cancer	3.35e-05	0.000358	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—VEGFA—brain cancer	3.31e-05	0.000353	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—TP53—brain cancer	3.31e-05	0.000353	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—STAT3—brain cancer	3.27e-05	0.00035	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SHH—brain cancer	3.25e-05	0.000347	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.24e-05	0.000346	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—PIK3CG—brain cancer	3.22e-05	0.000344	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SUFU—brain cancer	3.18e-05	0.00034	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NOTCH2—brain cancer	3.14e-05	0.000335	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TRPC6—brain cancer	3.13e-05	0.000335	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—TP53—brain cancer	3.11e-05	0.000332	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PTCH1—brain cancer	3.08e-05	0.000329	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SMO—brain cancer	3.08e-05	0.000329	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—GFAP—brain cancer	3.07e-05	0.000328	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.03e-05	0.000324	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—VAV1—brain cancer	2.99e-05	0.00032	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—BSG—brain cancer	2.98e-05	0.000319	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HEY1—brain cancer	2.91e-05	0.000311	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—DLL1—brain cancer	2.86e-05	0.000305	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—PIK3CG—brain cancer	2.78e-05	0.000297	CbGpPWpGaD
Irbesartan—JUN—Immune System—VAV1—brain cancer	2.71e-05	0.00029	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.59e-05	0.000276	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HES1—brain cancer	2.57e-05	0.000275	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—IDH1—brain cancer	2.56e-05	0.000274	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—PIK3CG—brain cancer	2.52e-05	0.00027	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—TP53—brain cancer	2.5e-05	0.000267	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—IL2—brain cancer	2.49e-05	0.000266	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NOTCH2—brain cancer	2.46e-05	0.000263	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PDGFRA—brain cancer	2.45e-05	0.000262	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SHH—brain cancer	2.43e-05	0.000259	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SPP1—brain cancer	2.38e-05	0.000254	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VAV1—brain cancer	2.35e-05	0.000251	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TRPC6—brain cancer	2.34e-05	0.00025	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—RELA—brain cancer	2.31e-05	0.000247	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PTCH1—brain cancer	2.3e-05	0.000246	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SMO—brain cancer	2.3e-05	0.000246	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—ERBB2—brain cancer	2.3e-05	0.000245	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP2C9—brain cancer	2.27e-05	0.000242	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL2—brain cancer	2.26e-05	0.000242	CbGpPWpGaD
Irbesartan—JUN—Immune System—PDGFRA—brain cancer	2.22e-05	0.000237	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IRS2—brain cancer	2.15e-05	0.00023	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.09e-05	0.000223	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ENO2—brain cancer	2.03e-05	0.000217	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HES1—brain cancer	2.02e-05	0.000216	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CTNNB1—brain cancer	2.01e-05	0.000215	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL2—brain cancer	1.96e-05	0.000209	CbGpPWpGaD
Irbesartan—JUN—Immune System—IRS2—brain cancer	1.95e-05	0.000208	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—BSG—brain cancer	1.93e-05	0.000206	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PDGFRA—brain cancer	1.92e-05	0.000205	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PIK3CG—brain cancer	1.9e-05	0.000203	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APC—brain cancer	1.9e-05	0.000203	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SPP1—brain cancer	1.87e-05	0.000199	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP2C9—brain cancer	1.86e-05	0.000199	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOTCH2—brain cancer	1.84e-05	0.000197	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2—brain cancer	1.78e-05	0.00019	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VAV1—brain cancer	1.75e-05	0.000187	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—EGFR—brain cancer	1.73e-05	0.000185	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IRS2—brain cancer	1.69e-05	0.00018	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—IDH1—brain cancer	1.66e-05	0.000177	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PIK3CG—brain cancer	1.65e-05	0.000176	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—EGFR—brain cancer	1.59e-05	0.00017	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—BSG—brain cancer	1.58e-05	0.000169	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP2C9—brain cancer	1.58e-05	0.000168	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—BSG—brain cancer	1.57e-05	0.000168	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HES1—brain cancer	1.51e-05	0.000161	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APC—brain cancer	1.49e-05	0.000159	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PIK3CG—brain cancer	1.49e-05	0.000159	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—RELA—brain cancer	1.48e-05	0.000159	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ERBB2—brain cancer	1.47e-05	0.000158	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PDGFRA—brain cancer	1.44e-05	0.000154	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SPP1—brain cancer	1.39e-05	0.000149	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—IDH1—brain cancer	1.36e-05	0.000145	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—EGFR—brain cancer	1.36e-05	0.000145	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.35e-05	0.000144	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—IDH1—brain cancer	1.35e-05	0.000144	CbGpPWpGaD
Irbesartan—JUN—Immune System—RELA—brain cancer	1.35e-05	0.000144	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—BSG—brain cancer	1.34e-05	0.000143	CbGpPWpGaD
Irbesartan—JUN—Immune System—ERBB2—brain cancer	1.34e-05	0.000143	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2—brain cancer	1.34e-05	0.000143	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ENO2—brain cancer	1.31e-05	0.00014	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCND1—brain cancer	1.3e-05	0.000139	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CTNNB1—brain cancer	1.29e-05	0.000138	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IRS2—brain cancer	1.26e-05	0.000135	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP2C9—brain cancer	1.22e-05	0.00013	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2—brain cancer	1.21e-05	0.00013	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTNNB1—brain cancer	1.17e-05	0.000125	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RELA—brain cancer	1.16e-05	0.000124	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ERBB2—brain cancer	1.16e-05	0.000124	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—IDH1—brain cancer	1.15e-05	0.000123	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—VEGFA—brain cancer	1.14e-05	0.000121	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—STAT3—brain cancer	1.12e-05	0.00012	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APC—brain cancer	1.11e-05	0.000119	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PIK3CG—brain cancer	1.11e-05	0.000119	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.1e-05	0.000117	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ENO2—brain cancer	1.07e-05	0.000115	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ENO2—brain cancer	1.07e-05	0.000114	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2—brain cancer	1.05e-05	0.000112	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MYC—brain cancer	1.05e-05	0.000112	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—BSG—brain cancer	1.03e-05	0.00011	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCND1—brain cancer	1.02e-05	0.000109	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—EGFR—brain cancer	1.02e-05	0.000109	CbGpPWpGaD
Irbesartan—JUN—Immune System—STAT3—brain cancer	1.02e-05	0.000109	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CTNNB1—brain cancer	1.01e-05	0.000108	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.38e-06	0.0001	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PIK3CG—brain cancer	9.3e-06	9.94e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—EGFR—brain cancer	9.27e-06	9.91e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ENO2—brain cancer	9.1e-06	9.73e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VEGFA—brain cancer	8.91e-06	9.53e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—IDH1—brain cancer	8.89e-06	9.5e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—STAT3—brain cancer	8.83e-06	9.44e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RELA—brain cancer	8.7e-06	9.3e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ERBB2—brain cancer	8.65e-06	9.24e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TP53—brain cancer	8.58e-06	9.18e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MYC—brain cancer	8.2e-06	8.77e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EGFR—brain cancer	8.02e-06	8.58e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2—brain cancer	7.84e-06	8.38e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCND1—brain cancer	7.64e-06	8.17e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CTNNB1—brain cancer	7.57e-06	8.09e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ENO2—brain cancer	7.03e-06	7.51e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TP53—brain cancer	6.74e-06	7.2e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VEGFA—brain cancer	6.66e-06	7.12e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—STAT3—brain cancer	6.59e-06	7.05e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MYC—brain cancer	6.13e-06	6.55e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PIK3CG—brain cancer	6.01e-06	6.42e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EGFR—brain cancer	5.99e-06	6.41e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TP53—brain cancer	5.03e-06	5.38e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PIK3CG—brain cancer	4.93e-06	5.27e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PIK3CG—brain cancer	4.89e-06	5.22e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PIK3CG—brain cancer	4.18e-06	4.46e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PIK3CG—brain cancer	3.22e-06	3.45e-05	CbGpPWpGaD
